CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Milestone Pharmaceuticals Fiscal Q4 2024 Earnings Report - CapyFin

Milestone Pharmaceuticals

MIST · NASDAQ🇨🇦

Overview Earnings

Dividends Seasonality Metrics

Q3 2025 Q2 2025 Q1 2025 Q4 2024 +7.89%Q3 2024 -5.15%Q2 2024 +6.02%Q1 2024 +1.18%Q4 2023 +16.00%Q3 2023 -23.02%Q2 2023 +1.60%Q1 2023 +12.82%Q4 2022 -4.01%Q3 2022 +12.96%Q2 2022 +3.56%Q1 2022 -2.53%Q4 2021 +12.37%Q3 2021 +24.11%Q2 2021 +0.19%Q1 2021 +0.54%Q4 2020 -6.61%Q3 2020 +6.13%Q2 2020 -1.80%Q1 2020 +0.32%Q4 2019 +7.40%Q3 2019 -4.22%Q2 2019 +7.81%Q1 2019 +3.36%Q4 2018 Q3 2018 Q2 2018 Q1 2018

Mar 24, 2025

•

Dec 31, 2024

Milestone Pharmaceuticals Q4 2024 Earnings Report

Estimated EPS:-$0.15

+50.0% YoY

Previous year: -$868K

Previous year: -$1.4M

Cash and Equivalents

Previous year: $66M

Previous year: -$9.25M

Previous year: $75.2M

Milestone Pharmaceuticals

Unlock previous datapoints

Milestone Pharmaceuticals

Unlock previous datapoints

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Milestone Pharmaceuticals